Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
Grupo Aeroportuario Centro Norte
OMAB
$4.36B
| $26.2M | 0.02% |
705,200
-193,500
| -22% | -$6.24M |
2014 Q3
23 quarters
|
|
677
Aflac
AFL
$57.4B
| $26.2M | 0.02% |
+726,300
| New | +$26.2M |
2020 Q2
0 quarters
|
|
678
Equinox Gold
EQX
$13.3B
| $26.1M | 0.02% |
2,325,000
+2,256,700
| +3,304% | +$20.2M |
2020 Q1
1 quarter
|
|
679
Myers Industries
MYE
$1.15B
| $26M | 0.02% |
1,789,397
-30,700
| -2% | -$381K |
2015 Q4
18 quarters
|
|
680
Quanex
NX
$838M
| $26M | 0.02% |
1,874,507
+34,509
| +2% | +$411K |
2013 Q4
26 quarters
|
|
681
Suzano
SUZ
$10.6B
| $26M | 0.02% |
3,843,738
-26,391
| -0.7% | -$193K |
2019 Q1
5 quarters
|
|
682
OR Royalties Inc
OR
$6.53B
| $26M | 0.02% |
2,598,300
-223,975
| -8% | -$2.07M |
2017 Q2
12 quarters
|
|
|
RST
683
DELISTED
ROSETTA STONE INC
RST
| $26M | 0.02% |
1,540,823
-23,700
| -2% | -$398K |
2013 Q2
28 quarters
|
|
684
10x Genomics
TXG
$10.5B
| $25.9M | 0.02% |
289,636
+279,100
| +2,649% | +$21.7M |
2020 Q1
1 quarter
|
|
685
Camping World
CWH
$289M
| $25.8M | 0.02% |
+949,400
| New | +$15.3M |
2020 Q2
0 quarters
|
|
|
CMA
686
DELISTED
Comerica
CMA
| $25.8M | 0.02% |
676,447
-25,219
| -4% | -$880K |
2019 Q4
2 quarters
|
|
|
IAA
687
DELISTED
IAA, Inc. Common Stock
IAA
| $25.6M | 0.02% |
665,000
+571,000
| +607% | +$21.3M |
2020 Q1
1 quarter
|
|
688
Nucor
NUE
$56.8B
| $25.6M | 0.02% |
619,180
+127,828
| +26% | +$5.17M |
2019 Q1
5 quarters
|
|
|
TWNK
689
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $25.6M | 0.02% |
2,097,410
+1,150,500
| +122% | +$13.6M |
2019 Q2
4 quarters
|
|
690
CNA Financial
CNA
$12.5B
| $25.5M | 0.02% |
794,400
-318,200
| -29% | -$9.8M |
2014 Q2
24 quarters
|
|
|
TTM
691
DELISTED
Tata Motors Limited
TTM
| $25.5M | 0.02% |
3,884,908
-3,493,900
| -47% | -$20.1M |
2016 Q1
17 quarters
|
|
|
NBL
692
DELISTED
Noble Energy, Inc.
NBL
| $25.4M | 0.02% |
2,839,528
-822,000
| -22% | -$7.35M |
2020 Q1
1 quarter
|
|
693
State Street Financial Select Sector SPDR ETF
XLF
$51.2B
| $25.4M | 0.02% |
+1,098,700
| New | +$24.9M |
2020 Q2
0 quarters
|
|
694
Robert Half
RHI
$3.47B
| $25.3M | 0.02% |
479,098
-17,700
| -4% | -$840K |
2018 Q3
7 quarters
|
|
|
GMS
695
DELISTED
GMS Inc
GMS
| $25.3M | 0.02% |
1,028,602
-378,900
| -27% | -$7.22M |
2018 Q3
7 quarters
|
|
|
NPTN
696
DELISTED
NEOPHOTONICS CORP
NPTN
| $25.3M | 0.02% |
2,845,784
+836,727
| +42% | +$7.21M |
2019 Q1
5 quarters
|
|
697
Trane Technologies
TT
$105B
| $25.3M | 0.02% |
283,833
+48,336
| +21% | +$4.2M |
2018 Q3
7 quarters
|
|
698
Hartford Financial Services
HIG
$35B
| $25.1M | 0.02% |
652,300
+615,500
| +1,673% | +$23.5M |
2020 Q1
1 quarter
|
|
699
TIM SA
TIMB
$8.54B
| $25.1M | 0.02% |
1,940,334
-171,862
| -8% | -$2.14M |
2016 Q2
16 quarters
|
|
700
CoreCivic
CXW
$3.26B
| $25M | 0.02% |
2,668,273
-1,730,200
| -39% | -$19.7M |
2015 Q3
19 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.